Virus elimination and inactivation continue to emerge as an important factor in overall bioprocess safety. As bioprocesses, products, and unit operations flourish, viral clearance will become more customized to industrial and individual situations. At the same time, the global viral clearance market will keep extending its purview. Viral clearance is also called viral safety. For example, in case of inactivation of reagents such as monoclonal antibodies and recombinant proteins, companies, CROs, and diagnostic testing labs need to evaluate the removal of specific viral strains or viral copy number in samples.
Viral clearance can be performed by numerous methods depending on product type, technique for production, and whether it is a medical device or not. Examples of the techniques used in viral clearance are qRT-PCR, PCR, real time PCR, ELISA (EIA), western blot, and transmission EM. Viral clearance is vital for final confirmation about the acceptable level of safety which can be taken in for a final product. The success ratio of viral clearance depends on the selection of suitable methods that make sure the removal or demolition of any viruses without disturbing the target protein. A number of factors must be considered when making this choice: the regulatory requirements, characteristics of the target protein, the mechanism(s) of clearance method(s), and the impact of process parameters.
The major driver of the global viral clearance market is increasing demand in the pharmaceutical and biotechnological industries. Rise in the number of new drug launches in various segments and associated drug approval processes are also boosting market growth. The global viral clearance market has been segmented based on technique, end-user, application, and region. Based on technique, the viral clearance market has been divided into viral detection method, viral removal method, and viral inactivation method. The viral detection method segment is estimated to account for the largest share of the global viral clearance market.
In terms of application, the market has been segmented into blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. The vaccines and therapeutics segment is projected to hold the largest market share. Based on end-user, the viral clearance market has been segmented into pharmaceutical and biotechnology companies, contract research organizations, academics and research institutes, and others. The others segment constitutes medical device companies, cell banks, small cell culture laboratories and consultants, microbiology laboratories, and toxicology laboratories.
Geographically, the global viral clearance market has been divided into North America, Europe, Asia Pacific, and Rest of the World (Latin America, Middle East, and Africa). In terms of region, North America accounted for the largest share of the viral clearance market, followed by Europe, and Asia. North America and Europe are likely to witness high demand for viral clearance assays as a result of technological advancement, rise in number of new drug launches, and patent expiry of popular branded drugs. Other factors driving the market in these regions are rapidly aging population, growing incidence of associated disease, and increased obesity rates.
The market in Asia Pacific is expected to expand at the highest growth rate during the forecast period. The considerable growth of the market in the region is attributable to growing public and private initiatives to increase awareness related to health and safety of medicinal treatment and constant growth in health care expenditure. Presence of a large chronically ill population, increasing number of private sector hospitals, rising affluence, advancements in technology, and expansion to rural health care infrastructure are also likely to drive the market.
Major companies operating in the viral clearance market are Avance Biosciences, Inc., BSL Bioservice, Charles River Laboratories International, Inc., Clean Cells, Inc., Lonza Group, Merck Millipore – Sigma-Aldrich, Texcell, Inc., and Wuxi Pharmatech (Cayman), Inc., among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Virus Clearance Market during 2016- 2024
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453